Target intelligence / Profile preview

Cell membrane phospholipids and lipid rafts

Molecular classification
Lipid, Cell membrane component, Lipid microdomain
01

Overview

Cell membrane phospholipids and lipid rafts are fundamental components of the cellular architecture that regulate the physical properties and functional organization of the plasma membrane. Phospholipids form the basic structural bilayer, while lipid rafts are specialized, highly ordered microdomains enriched in cholesterol and sphingolipids that serve as platforms for signal transduction and protein trafficking (Simons & Toomre, 2000). These structures are vital for maintaining cellular homeostasis, facilitating cell-cell communication, and coordinating the recruitment of signaling molecules like G proteins and tyrosine kinases. In various diseases, including cancer and neurodegeneration, alterations in lipid composition and raft stability contribute to pathological signaling and protein aggregation (Michel & Bakovic, 2007). Therapeutic targeting of these lipids, often referred to as membrane lipid therapy, aims to disrupt the life cycle of pathogens or reorganize signaling platforms in diseased cells to restore normal function (Escribá et al., 2008).

Other names
Plasma membrane lipidsLipid microdomainsDetergent-resistant membranesSphingolipid-cholesterol raftsMembrane bilayer
02

Mechanism of action

Drugs targeting cell membrane phospholipids and lipid rafts typically act by disrupting membrane integrity, forming trans-membrane pores, or displacing signaling proteins from lipid microdomains to inhibit aberrant signaling pathways (Escribá et al., 2008; Simons & Toomre, 2000).

03

Biological functions

Signal transductionMembrane traffickingCell-cell communicationPathogen entryProtein scaffoldingMembrane integrity
04

Disease associations

CancerInfectionNeurodegenerative diseaseCardiovascular diseaseMetabolic disorder
05

Safety considerations

HemolysisNephrotoxicityNon-specific membrane disruptionCytotoxicity to healthy cells
06

Interacting drugs

Amphotericin B

6 more in the full profile.

07

Biomarkers

Cholesterol levelsSphingomyelin concentrationGM1 ganglioside expressionLipidomic profile

Beyond the preview

Go deeper on Cell membrane phospholipids and lipid rafts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membrane phospholipids and lipid rafts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call